2nd International MPE Meeting

Examples of attendee’s affiliations: Harvard Medical School, Harvard School of Public Health, MIT, The Broad Institute, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Beth Israel Deaconess Medical Center, Massachusetts General Hospital, Children’s Hospital Boston, Memorial Sloan Kettering Cancer Center, American Cancer Society, NIH/NCI, Institute of Cancer Research UK, University of Tokyo, Keio University, Lund University, Mayo Clinic, University of Aberdeen, Vanderbilt University, Queen’s University Belfast, University of Washington, University of California San Francisco, Fred Hutchinson Cancer Research Center, National Cancer Center Japan, George Washington University, Mount Sinai School of Medicine, Albert Einstein College of Medicine, Maastricht University, Ewha Womans University.

http://www.globaleventslist.elsevier.com/events/2014/12/2nd-international-molecular-pathological-epidemiology-mpe-meeting/

The Second International Molecular Pathological Epidemiology (MPE) Meeting is a meeting open to research community around the world, with free registration.  We expect the implementation of Annual (or “1.5 year-nual”) International MPE Meeting.  The First International MPE Meeting was held as a closed meeting in Boston, MA on April 24, 2013, and it went very successfully.

The most important premise of epidemiology is that individuals with the same disease name have similar causes, and can be expected to exhibit a similar disease evolution.  In the past two decades, our knowledge on disease pathogenesis has improved considerably, and disease classification has also transformed, incorporating molecular mechanisms of disease.  Most epidemiology studies including molecular epidemiology studies have still relied on disease data from clinical records, which have been collected without detailed assessment of molecular pathology.  In a minority of epidemiology studies in the past decades, molecular pathology techniques have been used, typically under the umbrella term of “molecular epidemiology”.  This has hindered the development of not only specific methodologies to analyze disease heterogeneity and pathogenesis, but also standardized research guidelines.  In fact, STROBE-ME (molecular epidemiology) guidelines do not adequately address molecular pathology and heterogeneity of disease.

To advance integrative molecular and population-level health science and address the unique research challenges specific to the field of MPE requires bringing together experts in various fields including molecular pathology, epidemiology, biostatistics, bioinformatics, and nutritional and environmental sciences.  This effort of integrating seemingly divergent fields can lead to a greater understanding of heterogeneity of the pathogenic process, and the impact of environmental, dietary, lifestyle, and genetic factors and their interactions on that process.  Brainstorming and discussion fostered by the MPE Meeting will lead to the development of new methodologies to address the unique research questions and challenges in this emerging field.

Our specific aims of the MPE Meeting are:

1. To develop conceptual and practical framework of MPE
2. To cultivate and expand opportunities
3. To address challenges in MPE
4. To initiate effort of making guidelines in MPE research (“STROBE-MPE”)

This unique meeting can provide an unprecedented opportunity for interdisciplinary collaboration and integration of multiple diverse fields.  Eventually, we aim to establish the MPE Meeting as a regular annual science forum, where we can advance population science, and optimize our training and education systems for 21st century medicine and public health

Confirmed speakers, moderators and discussion leaders include:

• Adam Bass
• Andrew Beck
• Colin Begg
• Peter Campbell
• Andrew Chan
• Nilanjan Chatterjee
• Montserrat Garcia-Closas
• Edward Giovannucci
• Rafael Irizarry
• Karl Kelsey
• Aya Kuchiba
• Paul Lochhead
• Matthew Meyerson
• Lindsay Morton
• Lorelei Mucci
• Liam Murray
• Hongmei Nan
• Reiko Nishihara
• Shuji Ogino
• Ulrike Peters
• Amanda Phipps
• Elizabeth Poole
• Bernard Rosner
• Mark Sherman
• Stephanie Smith-Warner
• Donna Spiegelman
• Rulla Tamimi
• Eric Tchetgen Tchetgen
• Melissa Troester
• Shelley Tworoger
• Piet van den Brandt
• Molin Wang
• Kana Wu

Program Committee

• Shuji Ogino, Chairperson
• Andrew Beck
• Colin Begg
• Peter Campbell
• Kathryn Fitzgerald
• Edward Giovannucci
• Kentaro Inamura
• Rafael Irizarry
• Karin Jirström
• Karl Kelsey
• Sun A Kim
• Aya Kuchiba
• Paul Lochhead
• Nadine McCleary
• Hongmei Nan
• Akihiro Nishi
• Reiko Nishihara
• Amanda Phipps
• Elizabeth Poole
• Zhi Rong Qian
• Donna Spiegelman
• Eric Tchetgen Tchetgen
• Piet van den Brandt
• Molin Wang
• Kana Wu
• Xuehong Zhang

Poster referees

• Peter Campbell
• Paul Lochhead
• Hongmei Nan
• Amanda Phipps
• Zhi Rong Qian